Day: June 17, 2022

First demonstration of the survival of allogeneic islet cells, cardiomyocytes, and retinal pigment epithelium cells transplanted into an immunocompetent non-human primate model without any immune suppression The islet autoimmune data suggest that cells with hypoimmune (HIP) edits evade allogeneic immune response and autoimmune response in a type 1 diabetes mouse model Transplanting allogeneic cells into a non-human primate without immune suppression represents a key step toward development of engineered cells for the treatment of disease SEATTLE, June 17, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, presented data showing survival of transplanted allogeneic, hypoimmune cells of several different types in a variety of locations in non-human...

Results to be Presented in Late-Breaking Session SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, today announced that the Company will present one-year, safety and efficacy results from its HOPE-2 open-label extension study with lead asset CAP-1002 for treating Duchenne muscular dystrophy (DMD) at this year’s Parent Project Muscular Dystrophy (PPMD) Annual Conference. The details are as follows:Dr. Linda Marbán, CEO, will present the one-year open label extension results via a late-breaking session on June 25, 2022, at 5:05 p.m. MT. Capricor will also deliver a clinical update as part of PPMD’s “Novel Approaches for Combatting...

Customers in Toronto, Montreal, Ottawa, Edmonton and Victoria will enjoy an enhanced 5G experience made possible with newly deployed spectrum 3500 MHz 5G spectrum enables greater responsiveness and faster speeds, driving the advancement of IoT and industry solutions and important innovations in health, agriculture, energy, transportation and more VANCOUVER, British Columbia, June 17, 2022 (GLOBE NEWSWIRE) — TELUS is deploying new 3500 MHz spectrum on its next-generation 5G wireless network to further support the country’s economic growth and competitiveness, bringing enhanced capacity, low latency and even faster speeds to TELUS customers in Toronto, Montreal, Ottawa, Edmonton and Victoria, as part of its larger $220 billion investment in network infrastructure and operations in Canada since 2000. With the rollout of the 3500 MHz...

LAKE FOREST, Calif., June 17, 2022 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced the pricing of a public offering of 3,157,895 shares of its common stock (or pre-funded warrants in lieu thereof), together with warrants to purchase up to 3,157,895 shares of its common stock at an offering price to the public of $1.90 per share (or pre-funded warrant) and associated warrant. The warrants will have an exercise price of $1.90 per share, are exercisable upon issuance, and will expire five years following the date of issuance. The closing of the offering is expected to occur on or about June 22, 2022, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds...

POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) — BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies will be hosted on Benzinga’s All Access show, which airs on Benzinga TV and Benzinga’s YouTube channel on June 17 2022, at 10:20 AM EST. BioStem Technologies CEO Jason Matuszewski will be interviewed and provide updates on the latest developments in BioStem’s business growth and portfolio of products. A link to the YouTube broadcast will be available in our investor relations news portal at the below link: https://www.biostemtechnologies.com/news. Or watch or listen live to the All-Access broadcast via the Benzinga YouTube channel in the link below: https://www.youtube.com/watch?v=e86eV1JzMontserratDzo About...

ATHENS, Greece, June 17, 2022 (GLOBE NEWSWIRE) — TEN, Ltd. (“TEN” or the “Company”) (NYSE: TNP) a leading diversified crude, product and LNG tanker operator, today announced that the Company will report earnings for the first quarter ended on March 31, 2022, prior to the open of the market in New York on Thursday, June 30, 2022. That same morning, at 10:00 a.m. Eastern Time, TEN will host a conference call to review the results as well as management’s outlook for the business. The call, which will be hosted by TEN’s senior management, may contain information beyond that which is included in the earnings press release. Conference Call details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1844 654 9829 (US Toll Free Dial-In), or +1 2133202519 (US International...

In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 Vaccine elicited a strong immune response in this age group Three 3-µg doses had favorable safety profile similar to placebo in young children ages 6 months through 4 years in Phase 2/3 clinical trial Pfizer-BioNTech COVID-19 Vaccine now authorized in the U.S. for all individuals 6 months of age and olderNEW YORK and MAINZ, GERMANY, June 17, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine as a three 3-µg dose series for children 6 months through 4 years of age (also referred to as 6 months to less than 5 years of age). The 3-µg dose was carefully selected as the preferred dose for children under 5 years of age based on...

Grigeo AB (hereinafter – the Company) has received notifications on transactions concluded by persons discharging managerial responsibilities at Grigeo AB (see attachments). The transactions that were executed are share option agreements for the right to obtain Company’s shares in the future. The transactions were executed according to the Rules for Granting Shares as approved by Annual General meeting of the Company on 29 April 2022. Not earlier than after 3 years the employees who concluded the transactions shall be entitled to the right to receive shares of the Company free of charge. Gintautas PangonisPresident of Grigeo AB+370 5 243 5801AttachmentsNotification on manager transaction IKTNotification on manager transaction MNNotification on manager transaction SMNotification...

On 19 June 2020, Harju County Court approved the reorganization plan of AS Baltika (Baltika). The restructuring advisor needs to submit a report to the court and the impacted creditors every six months. The first report was submitted in December 2020. The fourth report is hereby published to all investors. The data and numbers in the report refer to Baltika on a stand-alone basis, not as a Group i.e. the numbers are not consolidated. The results of the first four months of 2022 were significantly affected by the war in Ukraine, which significantly reduced the number of store visits throughout the Baltics in the first weeks of March. In addition, during the first quarter, the entire Baltics continued to suffer from high a COVID-19 morbidity rate and this offered challenges in terms of day-to-day operations and, of course, store visits....

MONTVALE, N.J., June 17, 2022 (GLOBE NEWSWIRE) — MICT Inc. (Nasdaq: MICT) (the “Company), today announces that as previously disclosed it will announce its financial results for the fiscal year ended December 31, 2021 and file its Annual Report on Form 10-K for the same period, after market today. The Company plans to release these results today to avoid further delays due to a federal holiday on Monday, June 20, 2022, and within the deadline prescribed by Nasdaq. “I would like to thank the incredibly hard work of our finance department and our independent auditors in putting us in a position where we can announce our December 31, 2021 results today. Although the extremely strict COVID-19 lockdown protocols imposed throughout large parts of China prevented the completion of audit fieldwork on a timely basis, I am delighted for...